PRKAA2 and neoplasm: In contrast, 41% (7/17) of the [GFAP-tTA;TRE-SmoA1;AMPKα2−/−] mice survived beyond one year (Figure 2) and do not show any evidence of tumor upon histological analysis (Figure 1c).